VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
2 clinical trials · Sponsor
◉ Watch VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
| Record | Firm | Date |
|---|---|---|
| A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002) (NCT04504916) | VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2020-10-07 |
| A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001) (NCT03833180) | VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2019-03-14 |
Track VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) automatically
Every clearance here is in the API, with alerts when new ones post.